Highlands Oncology Group Physician Has Published New Research on Lung Cancer Treatment in Medical Journal
Dr. J. Thaddeus Beck, of Highlands Oncology Group (HOG), has been published for collaborative research done on targeted lung cancer treatment in Cancer Treatment Reviews.
The research focuses on an emerging treatment option for squamous cell lung carcinoma.
With lung cancer being the leading cause of cancer death, among both men and women, research on the treatment of lung cancer is vastly important.
Approximately 6.9 percent of men and women will be diagnosed with lung and bronchus cancer at some point during their lifetime, based on 2008-2010 data, according to the National Cancer Institute (NCI).
In 2011, there were an estimated 402,326 people living with lung and bronchus cancer in the United States, according to the NCI.
About 224,210 new cases of lung cancer with occur in the United States in 2014, according to the American Cancer Society, and an estimated 159,260 deaths from lung cancer.
Cancer Treatment Reviews is an international journal that helps keep both the clinician and researcher abreast of developments in cancer treatment research through the publication of state-of-the-art, authoritative reviews, according to their website.
Read more on the research here: http://ees.elsevier.com/ctr/
Highlands Oncology Group is a state-of-the-art facility, with a world-class team of specialists that is committed to providing premier cancer treatment and to enhancing the quality of life of patients and their loved ones. Highlands Oncology Group provides this in a friendly, comfortable environment, conveniently located in Northwest Arkansas. Highlands offers the latest technology in diagnostic imaging and radiation therapies, on-site labs, a pharmacy and an infusion center. They also offer access to clinical trials, multidisciplinary clinics and support groups. Highlands Oncology Group is helping patients win the battle against cancer every day.
For more information visit: www.HighlandsOncologyGroup.com